| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.0092 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0071 | 1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |